Stockreport

Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements

Orchestra BioMed Holdings, Inc. - Ordinary Shares  (OBIO) 
PDF New agreement grants Terumo Virtue SAB coronary indication right of first refusal and supersedes prior distribution agreementTerumo to pay a total of $30 million to Orch [Read more]